TCL Archive DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues January 22, 1988
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs June 16, 1999
TCL Archive Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot September 26, 2014
